Wednesday 22 May 2013

FDA Grants ‘Breakthrough’ Designation to Synageva Drug

FDA Grants ‘Breakthrough’ Designation to Synageva Drug

FDA, Peregrine Agree on Phase III Bavituximab Study

FDA, Peregrine Agree on Phase III Bavituximab Study

Bayer acquires Germany's Steigerwald Arzneimittelwerk, a privately held company specialising in herbal medicines

read all at

http://www.pharmaceutical-technology.com/news/newsbayer-acquires-herbal-medicines-manufacturer?WT.mc_id=DN_News
Bayer Pharmaceuticals has struck a deal to acquire Germany's Steigerwald Arzneimittelwerk, a privately held company specialising in herbal medicines

B-vitamins may delay Alzheimer’s onset

21 May 2013

News item thumbnail
Taking B-vitamins keeps brain tissue healthier for longer, and may help stave off dementia



read more
http://www.rsc.org/chemistryworld/2013/05/b-vitamins-slow-alzheimers-dementia  by

RSC Logo

Multitasking neurons found essential to the brain’s computational power

May 21, 2013


(Credit: iStockphoto)

There are many neurons, especially in brain regions that perform sophisticated functions such as thinking and planning, that react in different ways to a wide variety of things. MIT neuroscientist Earl Miller first noticed these unusual activity patterns about 20 years ago, while recording the electrical activity of neurons in animals that were trained to … more…

KurzweilAI | Accelerating Intelligence. Newsletter

Ranbaxy Laboratories gets tentative approval for HIV combination therapy